405 related articles for article (PubMed ID: 34070125)
1. Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
Chompunud Na Ayudhya C; Amponnawarat A; Ali H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070125
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
3. Identification of Gain and Loss of Function Missense Variants in MRGPRX2's Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P.
Chompunud Na Ayudhya C; Roy S; Alkanfari I; Ganguly A; Ali H
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652731
[TBL] [Abstract][Full Text] [Related]
4. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
5. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells
Amponnawarat A; Chompunud Na Ayudhya C; Ali H
Front Immunol; 2021; 12():689410. PubMed ID: 34248979
[No Abstract] [Full Text] [Related]
6. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
7. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
8. Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.
Alkanfari I; Gupta K; Jahan T; Ali H
J Immunol; 2018 Jul; 201(2):343-349. PubMed ID: 29794017
[TBL] [Abstract][Full Text] [Related]
9. Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses.
Callahan BN; Kammala AK; Syed M; Yang C; Occhiuto CJ; Nellutla R; Chumanevich AP; Oskeritzian CA; Das R; Subramanian H
Front Immunol; 2020; 11():703. PubMed ID: 32391014
[TBL] [Abstract][Full Text] [Related]
10. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
11. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.
Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2021; 12():803335. PubMed ID: 35126366
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.
Roy S; Chompunud Na Ayudhya C; Thapaliya M; Deepak V; Ali H
J Allergy Clin Immunol; 2021 Aug; 148(2):293-308. PubMed ID: 33957166
[TBL] [Abstract][Full Text] [Related]
14. Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation.
Che D; Zheng Y; Hou Y; Du X; Jia T; Zhao Q; Song X; Zhou T; Geng S
Int Immunopharmacol; 2021 Dec; 101(Pt B):108342. PubMed ID: 34753104
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
[TBL] [Abstract][Full Text] [Related]
16. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
17. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.
Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T
J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860
[TBL] [Abstract][Full Text] [Related]
18. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
19. In silico design of novel probes for the atypical opioid receptor MRGPRX2.
Lansu K; Karpiak J; Liu J; Huang XP; McCorvy JD; Kroeze WK; Che T; Nagase H; Carroll FI; Jin J; Shoichet BK; Roth BL
Nat Chem Biol; 2017 May; 13(5):529-536. PubMed ID: 28288109
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
